松果体区乳头状肿瘤:系统综述与预后因素分析
该系统综述纳入2003年至2017年71项研究共177例松果体区乳头状肿瘤患者,中位复发时间29个月,36个月生存率83.5%。多因素分析显示肿瘤大小(每增加1厘米HR 1.99)和手术治疗(HR 0.16)与36个月生存相关,未观察到全切除或辅助治疗的显著获益。
要点
- 肿瘤大小每增加1厘米,36个月死亡风险增加(HR 1.99)。
- 手术治疗与36个月生存改善相关(HR 0.16)。
- 全切除或辅助治疗未显示显著生存获益。
核心结论
- 肿瘤大小和手术治疗与松果体区乳头状肿瘤患者36个月生存改善相关。
- 未观察到全切除或辅助治疗带来显著获益。
研究设计与样本
- 检索2003年1月至2017年6月医学数据库的病例系列和病例报告。
- 初检1164项研究,最终纳入71项(60篇病例报告和11项病例系列),共177例患者,平均年龄33.0±15.3岁,男性占53.2%。
- 多因素分析最终样本为133例患者。
主要发现
- 颅内高压和脑积水是主要临床表现。
- 82.0%的患者接受手术,71.4%实现全切除。
- 56.8%的患者复发,中位复发时间29个月(四分位距10.5-45.5个月)。
- 36个月生存率为83.5%(95%CI 76.2-89.2%)。
- 60.0%的患者获得良好功能结局(格拉斯哥结局量表4/5分)。
临床怎么用
- 对于松果体区乳头状肿瘤患者,手术切除是改善36个月生存的重要治疗手段。
- 肿瘤大小可作为预后评估的参考因素,较大肿瘤可能提示更差生存。
- 全切除和辅助治疗对生存的获益尚不明确,需个体化决策。
局限性
- 感兴趣变量报告不一致,多因素分析最终样本仅133例。
- 纳入研究以病例报告和病例系列为主,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical outcomes and biological behavior of papillary tumors of the pineal region (PTPR) are still under investigation. The best therapeutic strategy has not been defined. OBJECTIVE: To perform a comprehensive patient-level analysis of all PTPR cases and identify their clinical features, treatment options, and prognostic factors. METHODS: A search of the medical databases for case series and reports on PTPRs from January 2003 to June 2017 was performed. Data addressing PTPR's clinical presentation, imaging, treatment, and histological features were. Variables associated with the primary outcome of 36-mo survival were identified through Cox regression models. RESULTS: The initial search yielded 1164 studies, of which 71 were included (60 case reports and 11 case series), containing 177 patients (mean age 33.0 ± 15.3 yr and 53.2% male). Intracranial hypertension and hydrocephalus prevailed as the clinical picture. Surgery was performed on 82.0% and gross total resection (GTR) was achieved on 71.4%. A total of 56.8% recurred after a median 29 mo (quartiles 10.5-45.5). The 36-mo survival rate was 83.5% (95% confidence interval [CI] 76.2-89.2%). Good functional outcomes (Glasgow Outcome Scale 4/5) were observed in 60.0%. The variables of interest were inconsistently reported and the multivariable analysis final sample was 133 patients. After adjustment for age, tumor size (each additional centimeter, hazard ratio [HR] 1.99, 95% CI 1.12-3.53, P = .019) and surgical treatment (HR 0.16, 95% CI 0.05-0.45, P = .001) were associated with 36-mo survival. CONCLUSION: Tumor size and surgery are associated with improvement in 36-mo survival. We did not observe any significant benefits from GTR or adjuvant treatments.
引用
- Yamaki VN, Solla DJF, Ribeiro RR, et al. Papillary Tumor of the Pineal Region: Systematic Review and Analysis of Prognostic Factors. Neurosurgery. 2019. PMID: 30989225. doi:10.1093/neuros/nyz062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。